Cardiometabolic Medicine: A Call for a New Subspeciality Training Track in Internal Medicine

被引:29
作者
Eckel, Robert H. [1 ]
Blaha, Michael J. [2 ]
机构
[1] Univ Colorado, Div Endocrinol Metab & Diabet, Anschutz Med Campus, Aurora, CO USA
[2] Johns Hopkins Sch Med, Div Cardiol, John Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21205 USA
关键词
CARDIOVASCULAR-DISEASE; MORTALITY;
D O I
10.1016/j.amjmed.2019.02.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:788 / 790
页数:3
相关论文
共 9 条
[1]  
Arps K, 2019, AM J MED
[2]   Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 1 [J].
Arps, Kelly ;
Pallazola, Vincent A. ;
Cardoso, Rhanderson ;
Meyer, Joseph ;
Jones, Richard, II ;
Latina, Jacqueline ;
Gluckman, Ty J. ;
Stone, Neil J. ;
Blumenthal, Roger S. ;
McEvoy, John W. .
AMERICAN JOURNAL OF MEDICINE, 2019, 132 (06) :E569-E580
[3]   Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment [J].
Danaei, Goodarz ;
Lu, Yuan ;
Singh, Gitanjali M. ;
Carnahan, Emily ;
Stevens, Gretchen A. ;
Cowan, Melanie J. ;
Farzadfar, Farshad ;
Lin, John K. ;
Finucane, Mariel M. ;
Rao, Mayuree ;
Khang, Young-Ho ;
Riley, Leanne M. ;
Mozaff, Dariush ;
Lim, Stephen S. ;
Ezzati, Majid ;
Aamodt, Geir ;
Abdeen, Ziad ;
Abdella, Nabila A. ;
Abdul Rahim, Hanan F. ;
Addo, Juliet ;
Aekplakorn, Wichai ;
Afifi, Mustafa M. ;
Agabiti-Rosei, Enrico ;
Salinas, Carlos A. Aguilar ;
Agyemang, Charles ;
Ali, Mohammed K. ;
Ali, Mohamed M. ;
Al-Nsour, Mohannad ;
Al-Nuaim, Abdul R. ;
Ambady, Ramachandran ;
Di Angelantonio, Emanuele ;
Aro, Pertti ;
Azizi, Fereidoun ;
Babu, Bontha V. ;
Bahalim, Adil N. ;
Barbagallo, Carlo M. ;
Barbieri, Marco A. ;
Barcelo, Alberto ;
Barreto, Sandhi M. ;
Barros, Henrique ;
Bautista, Leonelo E. ;
Benetos, Athanase ;
Bjerregaard, Peter ;
Bjoerkelund, Cecilia ;
Bo, Simona ;
Bobak, Martin ;
Bonora, Enzo ;
Botana, Manuel A. ;
Bovet, Pascal ;
Breckenkamp, Juergen .
LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (08) :634-647
[4]   2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [J].
Das, Sandeep R. ;
Everett, Brendan M. ;
Birtcher, Kim K. ;
Brown, Jenifer M. ;
Cefalu, William T. ;
Januzzi, James L., Jr. ;
Kalyani, Rita Rastogi ;
Kosiborod, Mikhail ;
Magwire, Melissa L. ;
Morris, Pamela B. ;
Sperling, Laurence S. ;
Ahmad, Tariq ;
Hucker, William ;
Kumbhani, Dharam J. ;
Marine, Joseph E. ;
Piana, Robert N. ;
Rao, Sunil V. ;
Scherrer-Crosbie, Marielle ;
Watson, Karol E. ;
Wiggins, Barbara S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (24) :3200-3223
[5]   The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction [J].
Newman, Jonathan D. ;
Vani, Anish K. ;
Aleman, Jose O. ;
Weintraub, Howard S. ;
Berger, Jeffrey S. ;
Schwartzbard, Arthur Z. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (15) :1856-1869
[6]   Cardiovascular Effects of New Oral Glucose-Lowering Agents DPP-4 and SGLT-2 Inhibitors [J].
Scheen, Andre J. .
CIRCULATION RESEARCH, 2018, 122 (10) :1439-1459
[7]   SGLT2 Inhibitors: Benefit/Risk Balance [J].
Scheen, Andre J. .
CURRENT DIABETES REPORTS, 2016, 16 (10)
[8]   Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals [J].
Sidney, Stephen ;
Quesenberry, Charles P., Jr. ;
Jaffe, Marc G. ;
Sorel, Michael ;
Nguyen-Huynh, Mai N. ;
Kushi, Lawrence H. ;
Go, Alan S. ;
Rana, Jamal S. .
JAMA CARDIOLOGY, 2016, 1 (05) :594-599
[9]   GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects? [J].
Zweck, Elric ;
Roden, Michael .
LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (02) :89-90